首页> 外文OA文献 >Efficacy and Tolerability of Levosulipride, Domperidone and Metoclopramide in Patients with Non-Ulcer Functional Dyspepsia: A Comparative Analysis
【2h】

Efficacy and Tolerability of Levosulipride, Domperidone and Metoclopramide in Patients with Non-Ulcer Functional Dyspepsia: A Comparative Analysis

机译:Levosuliprideride,Dumperidone和甲丙醇甲酰胺在非溃疡功能性消化患者中的疗效和耐受性:对比分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: This is a prospective, randomized study designedto demonstrate the efficacy of three study drugs (Levosulpiride,Domperidone and Metoclopramide) in Functional Dyspepsia.Subject recruitment was done from medicine outpatient departmentof the teaching hospital from June 2013 to November 2013.Materials and Methods: The data collection was performed by theShort-Form Leeds Dyspepsia Questionnaire (SF-LDQ), a questioninstrument for assessing the dyspeptic symptoms of functionaldyspepsia in patients enrolled for the study. The symptoms wereassessed at base line (Prior to initiation of therapy) and at 4 weeks,on a 5-point scale.Result: Among 120 patients 113 patients completed this study inthree groups (G-1 Levosulpiride 40 patients, G-2 Domperidone 35patients and G-3 Metoclopramide 38 patients) were followed up.Female gender dominated (75), occupation wise most of patientsbelonged to labour class (49). Highly significant improvement insymptoms scale was noticed in G-1 Levosulpiride 40 patients’group.Conclusion: Functional Gastrointestinal disorders are notserious ailments but have a key impact on quality of life. Overalldyspeptic symptom relief rates were significantly high in theLevosulpiride group (p<0.004) as compared to Domperidoneand Metoclopramide groups. A proper understanding of diseaseprocess by health care personnel and by sufferer is obligatory toenhance the quality of life and daunt the self/over the countermedication in this condition.
机译:目的:这是一个设计的预期,随机研究为了证明三种研究药物的疗效(Levosulpiride,DOMPERIDONE和甲氧丙普胺)在功能性消化不良。主题招聘是从医学门诊部完成的教学院2013年6月至2013年11月。材料和方法:数据收集是由短胸LEEDS消化不良问卷(SF-LDQ),一个问题用于评估功能性缺陷症状的仪器患有注册研究的患者的消化不良。症状是在碱基(在疗法开始之前)和4周评估,在5分的范围内。结果:120例患者中,113例患者完成了这项研究三组(G-1 Levosulpiride 40患者,G-2 Domperidone 35患者和G-3甲氧丙丙酰胺38例患者进行随访。女性性别主导(75),职业明智的大多数患者属于劳动课(49)。非常重要的改善G-1 Levosulpiride 40患者的症状规模被注意到团体。结论:功能性胃肠障碍不是严重的疾病,但对生活质量产生关键影响。总体功能性症状浮雕率明显高与Dumperidone相比,左旋素基团(P <0.004)和甲氯普胺基团。适当了解疾病通过医疗保健人员和受患者的过程是强制性的提升生活质量,并在柜台上涂抹这种情况下的药物。

著录项

  • 作者

    Harminder Singh;

  • 作者单位
  • 年度 2015
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号